Jazz Pharmaceuticals (JAZZ) News
NASDAQ: JAZZHealth CareBiotechnology: Pharmaceutical PreparationsUSD
218.42-4.03 (-1.81%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
JAZZ news summary
We found 1 recent headline mentioning Jazz Pharmaceuticals (JAZZ): 0 in the past week and 1 in the past 30 days, most often from Nasdaq. For price context, JAZZ is down 1.81% at $218.42. The most recent story, "New FDA Drug Approvals - August 2026", was published by Nasdaq on Sep 11, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology